Guest guest Posted January 3, 2011 Report Share Posted January 3, 2011 I think I read on this list that when the FDA held hearings to determine the fate of Azerra (the latest approved MAB) it was mentioneed that the FDA panel holding the hearings and making the decisions had no CLL expert. There may have been an oncologist or MD's/scientists etc, but no one our group would consider an expert. I believe Venkat and was it Dr. Kipps? did offer compelling testimony. If there is still no expert on the panel making decisions re. new drugs/treatment options, this is scary. Does anyone know? If there is no expert, is there a way to remedy this? R Adks NY and AZ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.